Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 08/31/23
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 09/22/16
End: 08/15/18
Due: 08/15/19
Phase: N/A
Priority: Normal
Start: 03/01/18
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer | NCT02388074 | bioAffinity Technologies Inc. | user2@example.com | None | 2015-03-31 | 2015-04-30 | 2016-04-30 | - | - | 2025-07-14 |
| Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay | NCT05870592 | bioAffinity Technologies Inc. | user2@example.com | None | 2023-08-31 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |
| Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer | NCT03837600 | bioAffinity Technologies Inc. | user2@example.com | None | 2016-09-22 | 2018-08-15 | 2019-08-15 | - | - | 2025-07-14 |
| Collection of Sputum and Labeling for Lung Cancer | NCT03457415 | bioAffinity Technologies Inc. | user2@example.com | None | 2018-03-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |